technetium tc 99m sestamibi has been researched along with Diarrheogenic Islet Cell Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Clermont, H; Rigabert, J | 1 |
| Cesani, F; Ernst, R; Villanueva-Meyer, J; Walser, E | 1 |
2 other study(ies) available for technetium tc 99m sestamibi and Diarrheogenic Islet Cell Tumor
| Article | Year |
|---|---|
[Diagnostic procedures and more particularly, place of scintigraphy in neuroendocrine tumors, example of vipoma in MEN 1].
Topics: Adult; Biomarkers; Calcitonin; Female; Humans; Hypercalcemia; Hyperparathyroidism; Magnetic Resonance Imaging; Multiple Endocrine Neoplasia Type 1; Neuroendocrine Tumors; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed; Vipoma | 2007 |
Tc-99m sestamibi imaging of a pancreatic VIPoma and parathyroid adenoma in a patient with multiple type I endocrine neoplasia.
Topics: Adenoma; Aged; Female; Humans; Multiple Endocrine Neoplasia; Pancreatic Neoplasms; Parathyroid Neoplasms; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Vipoma | 1994 |